Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO)
CUSIP: 869367102
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 84,733,230
- Total 13F shares
- 23,997,579
- Share change
- +12,616,282
- Total reported value
- $186,238,799
- Price per share
- $7.76
- Number of holders
- 76
- Value change
- +$97,614,730
- Number of buys
- 57
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 869367102:
Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SV Health Investors, LLC |
13F
|
Company |
2.2%
|
1,824,542
|
$18,610,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
1,549,354
|
$15,803,000 | — | 31 Mar 2020 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,285,975
|
$13,117,000 | — | 31 Mar 2020 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.3%
|
1,125,579
|
$11,481,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.78%
|
660,751
|
$6,738,000 | — | 31 Mar 2020 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.76%
|
641,268
|
$6,541,000 | — | 31 Mar 2020 | |
| Camber Capital Management LP |
13F
|
Company |
0.71%
|
600,000
|
$6,120,000 | — | 31 Mar 2020 | |
| BVF INC/IL |
13F
|
Company |
0.56%
|
475,482
|
$4,850,000 | — | 31 Mar 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.5%
|
425,000
|
$4,335,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.45%
|
378,131
|
$3,857,000 | — | 31 Mar 2020 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.34%
|
289,306
|
$2,951,000 | — | 31 Mar 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.27%
|
229,941
|
$2,346,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.21%
|
178,605
|
$1,822,000 | — | 31 Mar 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.2%
|
168,246
|
$1,714,000 | — | 31 Mar 2020 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.16%
|
139,331
|
$1,375,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
127,682
|
$1,302,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
119,453
|
$1,218,000 | — | 31 Mar 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.12%
|
104,800
|
$1,069,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.12%
|
101,860
|
$1,038,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0.11%
|
96,403
|
$983,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.1%
|
88,946
|
$908,000 | — | 31 Mar 2020 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
81,000
|
$826,000 | — | 31 Mar 2020 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.09%
|
74,385
|
$759,000 | — | 31 Mar 2020 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.08%
|
70,638
|
$721,000 | — | 31 Mar 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.08%
|
65,531
|
$668,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.07%
|
59,322
|
$605,000 | — | 31 Mar 2020 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.05%
|
40,000
|
$408,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
39,441
|
$403,000 | — | 31 Mar 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
39,365
|
$402,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
28,854
|
$295,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
26,475
|
$270,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
22,592
|
$231,000 | — | 31 Mar 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
22,282
|
$227,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
21,563
|
$220,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
21,442
|
$218,000 | — | 31 Mar 2020 | |
| Creative Planning |
13F
|
Company |
0.03%
|
21,273
|
$217,000 | — | 31 Mar 2020 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.02%
|
19,694
|
$201,000 | — | 31 Mar 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
16,946
|
$173,000 | — | 31 Mar 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
16,800
|
$171,000 | — | 31 Mar 2020 | |
| Spark Investment Management LLC |
13F
|
Company |
0.02%
|
14,587
|
$148,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
13,934
|
$142,000 | — | 31 Mar 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
13,798
|
$141,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.01%
|
11,216
|
$113,000 | — | 31 Mar 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
11,000
|
$112,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,628
|
$68,000 | — | 31 Mar 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,440
|
$66,000 | — | 31 Mar 2020 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.01%
|
6,389
|
$65,000 | — | 31 Mar 2020 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
3,475
|
$35,445 | — | 31 Mar 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3,382
|
$34,496 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
3,379
|
$34,000 | — | 31 Mar 2020 |
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) as of Q2 2020
As of 30 Jun 2020,
Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,997,579 shares.
The largest 10 holders included
BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, RA CAPITAL MANAGEMENT, L.P., EcoR1 Capital, LLC, SV Health Investors, LLC, Samsara BioCapital, LLC, BAILLIE GIFFORD & CO, CITADEL ADVISORS LLC, VANGUARD GROUP INC, and BlackRock Inc..
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
60
Q2 2020 holders
76
Holder diff
16
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.